Jci_page_head_homepage_01 Jci_page_head_homepage_02
Woei-Cherng Shyu, Demeral David Liu, Shinn-Zong Lin, Wen-Wen Li, Ching-Yuan Su, Ying-Chen Chang, Hsiao-Jung Wang, Hsing-Won Wang, Chang-Hai Tsai, Hung Li
Published in Volume 118, Issue 7
J Clin Invest. 2008; 118(7):2482–2495 doi:10.1172/JCI34363
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 7
Intracerebral transplantation of hOECs/ONFs enhanced neurite regeneration through upregulation of PrPC and CXCR4 expression.

(A) In immunohistochemical analysis, hOEC/ONF + IgG (control human IgG) implantation significantly improved neurite outgrowth in the penumbral area of rats in comparison with hOECs/ONFs plus Ab1 (PrPC-blocking antibody), hOECs/ONFs plus Ab2 (CXCR4-neutralizing antibody), and vehicle (Control) treatment. (B) hOEC/ONF + IgG (S) implantation produced neurites significantly longer than those found in rats treated with S + Ab1, S + Ab2, and vehicle (control [C]). Moreover, hOEC/ONF + IgG–treated rats had more neurite-bearing neurons than the control rats. (C) In colocalization analyses, PrPC and CXCR4 coexpressed around the region of bis-benzimide–labeled hOECs/ONFs and GFP+ cells on the cerebral ischemic microenviroment. (D) In a Western blot analysis, PrPC and CXCR4 expression was upregulated in the hOEC/ONF-treated rats compared with control rats. (E) The neurological behavior measurement modalities showed no significant difference between the 3 therapeutic groups (C, S + Ab1, S + Ab2). (F) In evaluating neurite regeneration, hOEC/ONF implantation in the PrPo/o mice did not increase the neurite length and number of neurite-bearing cells in contrast to those of PrP+/+ mice after cerebral ischemia. Data are expressed as mean ± SEM. *P < 0.05 and **P < 0.01 versus control. Scale bars: 50 μm.